Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics (Nasdaq: SGMO) has announced its participation in several upcoming investor conferences. Key events include the Cowen 41st Annual Health Care Conference on March 1 at 2:40 p.m. ET, the H.C. Wainwright Global Life Sciences Conference on March 9 at 7:00 a.m. ET, and the Barclays Global Healthcare Conference on March 10 at 10:55 a.m. ET. Live webcasts will be available on the company’s website under the Investors and Media section. Sangamo is focused on developing genomic medicines through innovative therapies.
- None.
- None.
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:
-
Cowen 41st Annual Health Care Conference
Date: Monday, March 1st at 2:40 p.m. Eastern Time
-
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9th at 7:00 a.m. Eastern Time
-
Barclays Global Healthcare Conference
Date: Wednesday, March 10th at 10:55 a.m. Eastern Time
For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005058/en/
FAQ
What are the dates for the investor conferences Sangamo Therapeutics is attending in March 2023?
What time will Sangamo present at the Cowen 41st Annual Health Care Conference?
Where can I find the webcast for Sangamo's presentations?
What is the focus of Sangamo Therapeutics as a company?